Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
AIM: To identify those mechanisms involved in the systemic and muscular response to exercise treatment, in two different Obstructive Chronic Pulmonary Disease (COPD) phenotypes (emphysema and non-emphysema). The investigators will evaluate the effect of exercise training, on exercise outcomes, peripheral muscle strength measures, dyspnea and quality of life indices, and markers of systemic inflammation and muscle repair.
SUBJECTS: The investigators will study 30 COPD patients in GOLD II-IV stages, with symptomatic disease. Patients will be differentiated into 2 different phenotypes: predominant-emphysema and non-predominant emphysema (15 subjects for each group), according to high resolution computed tomography (HRCT) scanning images, and after the specific analysis with the MeVisPulmo software. After patients are typified, they will be included in the 12- wk training programme. MEASURES(pre&post-training):Basic blood analysis, EKG, spirometry, blood gases, pletysmography, gas diffusion, maximal inspiratory and expiratory pressure (MIP,MEP), bioimpedanciometry, 1RM test and isometric strength determination, 6-min walking test (6MWT), maximal and submaximal cycle-ergometry, and dyspnea using the Mahler's Basal and Transitional Dyspnoea Indexes (BDI/TDI) and quality of life (Chronic Respiratory Disease Questionnaire [(CRDQ]) evaluation. Besides, the investigators will measure blood PCR and cytokines levels (IL6, IL8, IL10, IL12, TNF-α, IGF-1, and MIC-A & MIC-B). Muscle biopsies will be made (quadriceps) for detection of TNF-α, TNFR-I, TNFR-II, IGF-1Ea and MGF, IGF-1R, genes bound to biogenesis, markers of cell lesion-stress and myosin heavy chains (MyHC) type I and II, N-CAM/CD56 and Met & Desmin
| Condition | Intervention | Phase |
|---|---|---|
|
Obstructive Chronic Pulmonary Disease Emphysema Chronic Bronchitis |
Other: Combined Training (endurance and strength exercises) |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment |
| Official Title: | Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Chronic Obstructive Pulmonary Disease Phenotype |
- Change from baseline in TNF-alpha and its receptors, muscle isoforms of IGF-1 and its receptor in samples of quadriceps muscle satellite cells at 3 moths. [ Time Frame: Baseline and end of follow-up period of 3 moths ] [ Designated as safety issue: No ]Compare these values according to the phenotype of the patient (airway-predominant vs. emphysema-predominant) and assess the effect of the training program, according to the phenotype, the regenerative potential and muscle remodeling.
- Pax7, M-cadherin and Myo-D and its receptor in samples (molecules and repair-myogenesis) of quadriceps muscle satellite cells. [ Time Frame: Baseline and end of follow-up period of 3 moths ] [ Designated as safety issue: No ]Compare these values according to the phenotype of the patient (airway-predominant vs. emphysema-predominant) and assess the effect of the training program, according to the phenotype, the regenerative potential and muscle remodeling.
- MIC-A and MIC-B soluble in serum. [ Time Frame: Baseline and end of follow-up period of 3 moths. ] [ Designated as safety issue: No ]Compare these values according to the phenotype of the patient (airway-predominant vs. emphysema-predominant) and assess the effect of the training program, according to the phenotype. Determine whether the presence of these substances impact in terms of exercise capacity, nutritional status and muscle function.
- CRP, IL6, IL8, IL10, IL12, TNF alpha, IGF-1 (systemic inflammatory profile) in serum. [ Time Frame: Baseline and end of follow-up period of 3 moths. ] [ Designated as safety issue: No ]Compare these values according to the phenotype of the patient (airway-predominant vs. emphysema-predominant) and assess the effect of the training program, according to the phenotype. Determine whether the presence of these substances impact in terms of exercise capacity, nutritional status and muscle function.
| Estimated Enrollment: | 30 |
| Study Start Date: | January 2011 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: COPD with emphysema-predominant
The degree of involvement of the lung parenchyma and the airway are assessed by computed tomography. The HRCT is performed using 2-mm collimation, scan time 1.0 s, 120 kVp, and 200 mA. Images at three different levels (a cranial section is obtained 1 cm above the superior margin of the aortic arch, a middle section is taken at 1 cm below the carina, and a caudal section is taken approximately 3 cm above the top of the diaphragm) are selected and LAA% is then automatically calculated. The identification threshold of normal lung density and LAA is set at -960 HU. The cut-off level between high or low LAA% is the mean + 2SD of LAA% of the asymptomatic non-COPD smokers.
|
Other: Combined Training (endurance and strength exercises)
All patients underwent a training program to be held for 12 weeks in sessions of 60 minutes:
Other Name: Respiratory Rehabilitation
|
|
Active Comparator: COPD with airway-predominant
The degree of involvement of the lung parenchyma and the airway are assessed by computed tomography. The HRCT is performed using 2-mm collimation, scan time 1.0 s, 120 kVp, and 200 mA. Images at three different levels (a cranial section is obtained 1 cm above the superior margin of the aortic arch, a middle section is taken at 1 cm below the carina, and a caudal section is taken approximately 3 cm above the top of the diaphragm) are selected and LAA% is then automatically calculated. The helical scan is performed using 120 kVp, 50 mA, 3-mm collimation, and pith 1.0. The dimensions of the right apical segmental bronchus are measured and WA% is calculated. The cut-off level between high or low WA% is the mean + 2SD of WA% of the asymptomatic non-COPD smokers.
|
Other: Combined Training (endurance and strength exercises)
All patients underwent a training program to be held for 12 weeks in sessions of 60 minutes:
Other Name: Respiratory Rehabilitation
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 45 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- COPD patients diagnosed according to criteria established by the ATS (American Thoracic Society) and the SEPAR (Spanish Society of Pneumology and Thoracic Surgery) obstruction presenting moderate to severe airway obstruction (FEV1 <60%) and a clinical impact of their disease. Patients should be stable and appropriate therapy, and must not have suffered exacerbations of the disease over a period of three months before the study, and without treatment with oral corticosteroids for at least the same period.
Exclusion Criteria:
- Other cardio-respiratory diseases, cardiovascular, neuromuscular or metabolic might interfere with the results.
- Systemic diseases, alcohol intake (> 80 g / day) or treatment with drugs with potential effect on muscle structure
- Inability or disagree to participate in an exercise program.
Contacts and Locations| Contact: Ortega F Ruiz, Doctor | 955013172 | med000521@saludalia.com |
| Spain | |
| Hospital Universitario Virgen del Rocío | Recruiting |
| Sevilla, Spain, 41013 | |
| Contact: Marquez E Marquez, Doctor 656486927 eduardomarquezmartin@hotmail.com | |
| Contact: Valencia B Azcona, Doctor 669102839 borja_valencia_azcona@hotmail.com | |
| Principal Investigator: | Ortega F Ruiz, Doctor | Hospital Universitario Virgen del Rocío |
More Information
No publications provided
| Responsible Party: | Francisco Ortega Ruiz, Head of Section of Pneumology, Hospitales Universitarios Virgen del Rocío |
| ClinicalTrials.gov Identifier: | NCT01431625 History of Changes |
| Other Study ID Numbers: | 02/0529 |
| Study First Received: | September 6, 2011 |
| Last Updated: | September 8, 2011 |
| Health Authority: | Spain: Comité Ético de Investigación Clínica |
Keywords provided by Hospitales Universitarios Virgen del Rocío:
|
COPD Exercise Training |
Additional relevant MeSH terms:
|
Bronchitis Bronchitis, Chronic Emphysema Pulmonary Emphysema Inflammation Lung Diseases Respiration Disorders |
Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Bronchial Diseases Respiratory Tract Diseases Respiratory Tract Infections Pathologic Processes |
ClinicalTrials.gov processed this record on May 21, 2013